Perrigo's Next Private Label First Lands With Second Thoughts On Outlook
This article was originally published in The Pink Sheet
Executive Summary
The launch of a private label version 24HR OTC heartburn treatment comes with Perrigo in need of another high-selling product to boost revenues in its core business, OTC private label. But analysts call for Perrigo to do more to grow in new markets.